Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2020-03-16 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 95% confidence The document is a short announcement (427 characters) regarding transactions in Novozymes' share buyback program. It explicitly directs the reader to an attached file for the full details. According to the 'Menu vs Meal' rule, an announcement of a report or transaction details that directs the user to an attachment is classified as a Report Publication Announcement (RPA).
2020-03-16 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement of transactions under Novozymes' stock buyback program, including the number of shares purchased, transaction values, dates, and regulatory compliance references. It provides specific trading data and accumulated shares bought back under the program. There is no indication of financial results, earnings, management discussion, or other report types. The content clearly relates to the company's repurchase of its own shares, which fits the category of Transaction in Own Shares (POS). The document length is substantial and contains detailed transaction data, not just a brief announcement or reference to a report. Therefore, the correct classification is POS with high confidence.
2020-03-16 English
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (401 characters) and explicitly states, 'Please read the full announcement in the attached PDF' and provides a link to a document titled 'Stock Buybackprogram'. This indicates the document itself is merely an announcement about the availability of the full report, not the report content itself. The topic is the company transacting in its own shares (stock buyback). According to the definitions, 'Transaction in Own Shares' is coded as POS. However, given the 'MENU VS MEAL' rule, since this is an announcement pointing to the full document, it should be classified as a Report Publication Announcement (RPA) or potentially a general Regulatory Filing (RNS) if RPA is too specific for a buyback announcement. Since POS is a specific transaction type, and RPA covers the announcement of publication, RPA is a strong candidate. However, the core subject matter is 'Transaction in Own Shares' (POS). Given the brevity and the instruction to read the attachment, RPA is the most appropriate classification for the *announcement* itself, as per Rule 2. If the content were the actual transaction details, it would be POS. I will classify it as RPA because it is an announcement of publication.
2020-03-16 English
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 100% confidence The document text is titled "Transaktioner i forbindelse med Novozymes' aktietilbagekøbsprogram" (Transactions related to Novozymes' share buyback program) and details the number of shares bought back, the transaction value, and specific daily trade data (dates in March 2020). This content directly relates to the company repurchasing its own shares. According to the definitions, this corresponds to 'Transaction in Own Shares' (Code: POS). The document is a detailed report/announcement of these transactions, not merely an announcement of a report's publication.
2020-03-16 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement of transactions related to Novozymes' share buyback program, including the number of shares repurchased, transaction values, and dates. It references the share repurchase program initiated in 2020 and provides detailed trading data. There is no indication of financial statements, earnings data, or management discussion. The content focuses exclusively on the company's repurchase of its own shares, which fits the definition of a Transaction in Own Shares (POS) filing. The document length is substantial and contains detailed transaction data, confirming it is the report itself, not just an announcement of a report.
2020-03-09 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 95% confidence The document is a short announcement (427 characters) regarding transactions in Novozymes' share buyback program. It explicitly directs the reader to an attached file for the full details. According to the 'Menu vs Meal' rule, an announcement of a report or transaction details that directs the user to an attachment is classified as a Report Publication Announcement (RPA).
2020-03-09 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.